Inflammation markers predicting frailty and mortality in the elderly

Experimental and Molecular Pathology

Volumn 80, Issue 3, 2006, Pages 219-227

  De Martinis, Massimo ^a   Franceschi, Claudio ^b   Monti, Daniela ^c   Ginaldi, Lia ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Elderly; Frailty; Inflammation markers

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CELL MARKER; CYTOKINE; CYTOKINE RECEPTOR; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; SOMATOMEDIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

AGING; ALZHEIMER DISEASE; ANEMIA; ANOREXIA; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CEREBROVASCULAR DISEASE; CHRONIC LUNG DISEASE; CONGESTIVE HEART FAILURE; DNA POLYMORPHISM; FRAIL ELDERLY; GENETIC MARKER; HUMAN; MEMORY CELL; MORTALITY; MUSCLE ATROPHY; NEUTROPHIL COUNT; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOPOROSIS; PHENOTYPE; REVIEW; RHEUMATOID ARTHRITIS; SEROLOGY; THROMBOEMBOLISM;

AGED; AGED, 80 AND OVER; AGING; BIOLOGICAL MARKERS; FRAIL ELDERLY; HUMANS; INFLAMMATION;

EID: 33646518593     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2005.11.004     Document Type: Review

References (100)

1. Abbatecola A.M., Ferrucci L., Grella R., et al. Diverse effect of inflammatory markers on insulin resistance and insulin-resistance syndrome in the elderly. J. Am. Geriatr. Soc. 52 (2004) 399-404
2. Anisimov V.N. Insulin/IGF-1 signaling pathway driving aging and cancer as a target for pharmacological intervention. Exp. Gerontol. 38 (2003) 1041-1049
3. Appay V., and Rowland-Jones S.L. Premature ageing of the immune system: the cause of AIDS?. Trends Immunol. 23 (2002) 580-585
4. Ballantyne C.M., Nambi V., et al. Markers of inflammation and their clinical significance. Atherosclerosis, Suppl. 6 (2005) 21-29
5. Barbieri M., Ferrucci L., Ragno E., et al. Chronic inflammation and the effect of IGF-I on muscle strength and power in older persons. Am. J. Physiol.: Endocrinol. Metab. 284 (2003) 481-487
6. Bo S., Gambino R., Uberti B., et al. Does C-reactive protein identify a subclinical metabolic disease in healthy subjects?. Eur. J. Clin. Invest. 35 (2005) 265-270
7. Bogaty P., Brophy J.M., Boyer L., et al. Fluctuating inflammatory markers in patients with stable ischemic heart disease. Arch. Intern. Med. 165 (2005) 221-226
8. Bonafè M., Olivieri F., Cavallone L., et al. A gender-dependent genetic predisposition to produce high levels of IL-6 is detrimental for longevity. Eur. J. Immunol. 31 (2001) 2357-2361
9. Boren E., and Gershwin M.E. Inflamm-aging: autoimmunity, and the immune-risk phenotype. Autoimmun. Rev. 3 (2004) 401-406
10. Bruunsgaard H., and Pedersen B.K. Age-related inflammatory cytokines and disease. Immunol. Allergy Clin. North Am. 23 (2003) 15-39
11. Bruunsgaard H., Andersen-Ranberg K., Jeune B., et al. A high plasma concentration of TNF-alpha is associated with dementia in centenarians. J. Gerontol. Med. Sci. 54 (1999) 357-364
12. Bruunsgaard H., Skinhoj P., Pedersen A.N., et al. Ageing, TNF-alpha and atherosclerosis. Clin. Exp. Immunol. 121 (2000) 255-260
13. Bruunsgaard H., Pederson M., and Pederson B.K. Aging and proinflammatory cytokines. Curr. Opin. Hematol. 8 (2001) 131-136
14. Bruunsgaard H., Ladelund S., Pedersen A.N., et al. Predicting death from tumour necrosis factor-alpha and interleukin-6 in 80-year-old people. Clin. Exp. Immunol. 132 (2003) 24-31
15. Bruunsgaard H., Andersen-Ranberg K., Hjelmborg J.B., et al. Elevated levels of tumor necrosis factor alpha and mortality in centenarians. Am. J. Med. 115 (2003) 278-283
16. Cappola A.R., Xue Q.-L., Ferrucci L., et al. Insulin-like growth factor I and interleukin-6 contribute synergistically to disability and mortality in older women. J. Clin. Endocrinol. Metab. 88 (2003) 2019-2025
17. Carrieri G., Marzi E., Olivieri F., et al. The G/C915 polymorphism of transforming growth factor beta 1 is associated with human longevity: a study in Italian centenarians. Aging Cell 3 (2004) 443-448
18. Casiglia E., and Palatini P. Cardiovascular risk factors in the elderly. J. Hum. Hypertens. 12 (1998) 575-581
19. Cawthon R.M., Smith K.R., O'Brien E., et al. Association between telomere length in blood and mortality in people aged 60 years or older. Lancet 361 (2003) 393-395
20. Cesari M., Penninx B.W., Newman A.B., et al. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation 108 (2003) 9049-9050
21. Cesari M., Penninx B.W., Pahor M., et al. Inflammatory markers and physical performance in older persons: the InCHIANTI study. J. Gerontol., Ser. A, Biol. Sci. Med. Sci. 59 (2004) 242-248
22. Cooper R.S. Gene-environment interactions and the etiology of common complex disease. Ann. Int. Med. 139 (2003) 445-449
23. De Martinis M., Modesti M., Loreto M.F., et al. Adhesion molecules on peripheral blood lymphocyte subpopulations in the elderly. Life Sci. 68 (2000) 139-145
24. De Martinis M., Modesti M., Profeta V.F., et al. CD50 and CD62L adhesion receptor expression on naïve (CD45RA+) and memory (CD45RO+) T lymphocytes in the elderly. Pathobiology 68 (2000) 245-250
25. De Martinis M., Modesti M., and Ginaldi L. Phenotypic and functional changes of circulating monocytes and polymorphonuclear leucocytes from elderly persons. Immunol. Cell Biol. 82 (2004) 415-420
26. De Martinis M., Franceschi C., Monti D., and Ginaldi L. Inflamm-ageing and lifelong antigenic load as major determinants of ageing rate and longevity. FEBS Lett. 579 (2005) 2035-2039
27. Di Iorio A., Ferrucci L., Sparvieri E., et al. Serum IL-1β levels in health and disease: a population-based study. The InCHIANTI study. Cytokine 22 (2003) 198-205
28. Effros R.B. Replicative senescence of CD8 T cells: effect on human ageing. Exp. Gerontol. 39 (2004) 517-524
29. Effros R.B., Dagarag M., Spaulding C., and Man J. The role of CD8 T-cell replicative senescence in human aging. Immunol. Rev. 205 (2005) 147-157
30. Fagnoni F.F., Vescovini R., Passeri G., et al. Shortage of circulating naive CD8+ T cells provides new insights on immunodeficiency in aging. Blood 95 (2000) 2860-2868
31. Ferguson F.G., Wikby A., Maxson P., et al. Immune parameters in a longitudinal study of a very old population of Swedish people: a comparison between survivors and non survivors. J. Gerontol., Ser. A, Biol. Sci. Med. Sci. 50 (1995) 378-382
32. Franceschi C., and Bonafè M. Centenarians as a model for healthy aging. Biochem. Soc. Trans. 31 (2003) 457-461
33. Franceschi C., Monti D., Sansoni P., and Cossarizza A. The immunology of exceptional individuals: the lesson of centenarians. Immunol. Today 16 (1995) 12-16
34. Franceschi C., Valensin S., Fagnoni F., et al. Biomarkers of immunosenescence within an evolutionary perspective: the challenge of heterogeneity and the role of antigenic load. Exp. Gerontol. 34 (1999) 911-921
35. Franceschi C., Bonafè M., and Valensin S. Human immunosenescence: the prevailing of innate immunity, the failing of clonotypic immunity, and the filling of immunological space. Vaccine 18 (2000) 1717-1720
36. Franceschi C., Bonafè M., Valensin S., et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N. Y. Acad. Sci. 908 (2000) 244-254
37. Franceschi C., Valensin S., Lescai F., et al. Neuroinflammation and the genetics of Alzheimer's disease: the search for a pro-inflammatory phenotype. Aging Clin. Exp. Res. 13 (2001) 163-170
38. Franceschi C., Olivieri F., Marchegiani F., et al. Genes involved in immune response/inflammation, IGF1/insulin pathway and response to oxidative stress play a major role in the genetics of human longevity: the lesson of centenarians. Mech. Ageing Dev. 126 (2005) 351-361
39. Gangemi S., Basile G., Merendino R.A., et al. Increased circulating interleukin-18 levels in centenarians with no signs of vascular disease: another paradox of longevity?. Exp. Gerontol. 38 (2003) 669-672
40. Geenen V., Poulin J.F., Dion M.L., et al. Quantification of T cell receptor rearrangement excision circles to estimate thymic function: an important new tool for endocrine-immune physiology. J. Endocrinol. 176 (2003) 305-311
41. Ginaldi L., and Sternberg H. The immune system. In: Timiras P.S. (Ed). Physiological Basis of Aging and Geriatrics. 3rd ed. (2003), CRC Press, New York 265-283
42. Ginaldi L., De Martinis M., Modesti M., et al. Immunophenotypical changes of T lymphocytes in the elderly. Gerontology 46 (2000) 242-248
43. Ginaldi L., De Martinis M., D'Ostilio A., et al. Changes in the expression of surface receptors on lymphocyte subsets in the elderly: quantitative flow cytometric analysis. Am. J. Hematol. 67 (2001) 63-72
44. Ginaldi L., De Martinis M., Monti D., and Franceschi C. The immune system in the elderly: activation-induced and damage-induced apoptosis. Immunol. Res. 30 (2004) 81-94
45. Ginaldi L., De Martinis M., Monti D., and Franceschi C. Chronic antigenic load and apoptosis in immunosenescence. Trends Immunol. 26 (2005) 79-84
46. Girndt M., Kaul H., Sester U., et al. Anti-inflammatory interleukin-10 genotype protects dialysis patients from cardiovascular events. Kidney Int. 62 (2002) 949-955
47. Haddad F., Zaldivar F., Cooper D.M., and Adams G.R. IL-6-induced skeletal muscle atrophy. J. Appl. Physiol. 98 (2005) 911-917
48. Hajeer A.H., and Hutchinson I.V. Influence of TNFalpha gene polymorphisms on TNFalpha production and disease. Hum. Immunol. 62 (2001) 1191-1199
49. Harris T.B., Ferrucci L., Tracy R.P., et al. Association of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am. J. Med. 106 (1999) 506-512
50. Hoffmeister A., Rothenbacher D., Kunze M., et al. Prognostic value of inflammatory markers alone and in combination with blood lipids in patients with stable coronary artery disease. Eur. J. Intern. Med. 16 (2005) 47-52
51. Leng S., Xue Q.L., Huang Y., et al. Total and differential white blood cell counts and their associations with circulating interleukin-6 levels in community-dwelling older women. J. Gerontol., Ser. A, Biol. Sci. Med. Sci. 60 (2005) 95-99
52. Licastro F., Grimaldi L.M.E., Bonafè M., et al. Interleukin-6 gene alleles affect the risk of Alzheimer's disease and levels of the cytokine in blood and brain. Neurobiol. Aging 5831 (2003) 1-6
53. Lio D., Scola L., Crivello A., et al. Gender-specific association between -1082 IL-10 promoter polymorphism and longevity. Genes Immun. 3 (2002) 30-33
54. Lio D., Scola L., Crivello A., et al. Inflammation, genetics, and longevity: further studies on the protective effects in men of IL-10 -1082 promoter SNP and its interaction with TNF-α-308 promoter SNP. J. Med. Genet. 40 (2003) 496-499
55. Luciani F., Valensin S., Vescovini R., et al. A stochastic model for CD8+ T cell dynamics in human immunosenescence: implications for survival and longevity. J. Theor. Biol. 213 (2001) 587-597
56. Margolis K.L., Manson J.E., Greenland P., et al. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study. Arch. Intern. Med. 165 (2005) 500-508
57. Mariani E., Pulsatelli L., Neri S., et al. RANTES and MIP-1alpha production by T lymphocytes, monocytes and NK cells from nonagenarian subjects. Exp. Gerontol. 37 (2002) 219-226
58. Mazer S.P., and Rabbani L.E. Evidence for C-reactive protein (CRP)'s role in vascular disease: atherothrombosis, immuno-regulation and CRP. J. Thromb. Thrombolysis 17 (2004) 95-105
59. Mooradian A.D., Reed R.L., Osterweil D., and Scuderi P. Detectable serum levels of tumor necrosis factor alpha may predict early mortality in elderly institutionalized patients. J. Am. Geriatr. Soc. 39 (1991) 891-894
60. Mottonen M., Heikkinen J., Mustonen L., et al. CD4+CD25+T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis. Clin. Exp. Immunol. 140 (2005) 360-367
61. Nilsson B.O., Ernerudh J., Johansson B., et al. Morbidity does not influence the T cell immune risk phenotype in the elderly: findings in the Swedish NONA immune study using sample selection protocols. Mech. Ageing Dev. 124 (2003) 469-476
62. Olivieri F., Bonafè M., Giovagnetti S., et al. In vitro IL-6 production by EBV-immortalized B lymphocytes from young and elderly people genotyped for -174 C/G polymorphism in IL-6 gene: a model to study the genetic basis of inflamm-aging. Mech. Ageing Dev. 124 (2003) 549-553
63. Olsson J., Wikby A., Johansson B., et al. Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study. Mech. Ageing Dev. 121 (2000) 187-201
64. Ouyang Q., Wagner W.M., Voehringer D., et al. Age-associated accumulation of CMV-specific CD8+ T cells expressing the inhibitory killer cell lectin-like receptor G1 (KLRG1). Exp. Gerontol. 38 (2003) 911-920
65. Pawelec G., Ferguson F.G., and Wikby A. The SENIEUR protocol after 16 years. Mech. Ageing Dev. 122 (2001) 132-134
66. Pawelec G., Ouyang Qin, Colonna-Romano G., et al. Is human immunosenescence clinically relevant? Looking for "immunological risk phenotype". Trends Immunol. 23 (2002) 330-332
67. Pawelec G., Akbar A., Caruso C., et al. Human immunosenescence: is it infectious?. Immunol. Rev. 205 (2005) 257-268
68. Pawelec G., Akbar A., Caruso C., et al. Is immunosenescence infectious?. Trends Immunol. 205 (2005) 257-268
69. Pearson T.A., Mensah G.A., Alexander R.W., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 177 (2003) 499-511
70. Perls T., and Terry D. Understanding the determinants of exceptional longevity. Ann. Int. Med. 139 (2003) 445-449
71. Rea I.M. Ageing in the 21st century. Where to and how will we get there? Report on the 10th congress of the international association of biomedical gerontology, the geriatrician's view. Exp. Gerontol. 39 (2004) 283-284
72. Rea I.M., Ross O.A., Armstrong M., et al. Interleukin-6-gene C/G 174 polymorphism in nonagenarian and octogenarian subjects in the BELFAST study. Reciprocal effects on IL-6, soluble IL-6 receptor and for IL-10 in serum and monocyte supernatants. Mech. Ageing Dev. 124 (2003) 555-561
73. Recasens M., Lopez-Bermejo A., Ricart W., et al. An inflammation score is better associated with basal than stimulated surrogate indexes of insulin resistance. J. Clin. Endocrinol. Metab. 90 (2005) 112-116
74. Ridker P.M. C-reactive protein and risks of future myocardial infarction and thrombotic stroke. Eur. Heart J. 19 (1998) 1-3
75. Ridker P.M., Hennekens C.H., Buring J.E., et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N. Engl. J. Med. 342 (2000) 836-843
76. Ross O.A., Curran M.D., Meenagh A., et al. Study of age-association with cytokine gene polymorphisms in an aged Irish population. Mech. Ageing Dev. 124 (2003) 199-206
77. Roubenoff R. Catabolism of aging: is it an inflammatory process?. Curr. Opin. Clin. Nutr. Metab. Care 6 (2003) 295-299
78. Roubenoff R., Parise H., Payette H.A., et al. Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham heart study. Am. J. Med. 115 (2003) 429-435
79. Sandmand M., Bruunsgaard H., Kemp K., et al. High circulating levels of tumor necrosis factor-α in centenarians are not associated with increased production in T lymphocytes. Gerontology 49 (2003) 155-160
80. Sebestjen M., Keber I., Zegura B., et al. Statin and fibrate treatment of combined hyperlipidemia: the effects on some novel risk factors. Thromb. Haemost. 92 (2004) 1129-1135
81. Semba R.D., Margolick J.B., Leng S., et al. T cell subsets and mortality in older community-dwelling women. Exp. Gerontol. 40 (2005) 81-87
82. Sester M., Sester U., Gartner B., et al. Sustained high frequencies of specific CD4 T cells restricted to a single persistent virus. J. Virol. 76 (2002) 3748-3755
83. Shehab A.M., MacFadyen R.J., McLaren M., et al. Sudden unexpected death in heart failure may be preceded by short term, intraindividual increases in inflammation and in autonomic dysfunction: a pilot study. Heart 90 (2004) 1263-1268
84. Shetty G.K., Economides P.A., Horton E.S., et al. Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care 27 (2004) 2450-2457
85. Silvestri A., Vitale C., Ferretti F., et al. Plasma levels of inflammatory C-reactive protein and interleukin-6 predict outcome in elderly patients with stroke. J. Am. Geriatr. Soc. 52 (2004) 1586-1587
86. Sjoholm A., and Nystrom T. Endothelial inflammation in insulin resistance. Lancet 365 (2005) 610-612
87. Szmitko P.E., Wang C.-H., and Weisel R.D. New markers of inflammation and endothelial cell activation. Circulation 108 (2003) 1917-1923
88. Terry C.F., Loukaci V., and Green F.R. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J. Biol. Chem. 275 (2000) 18138-18144
89. Tomiyama H., Matsuda T., and Takiguchi M. Differentiation of human CD8+ T cells from a memory to memory/effector phenotype. J. Immunol. 168 (2002) 5538-5550
90. Tracy R.P. Emerging relationships of inflammation, cardiovascular disease and chronic diseases of aging. Int. J. Obes. Relat. Metab. Disord. 27 (2003) 29-34
91. Valenzuela H.F., and Effros R.B. Divergent telomerase and CD28 expression patterns in human CD4 and CD8 T cells following repeated encounters with the same antigenic stimulus. Clin. Immunol. 105 (2002) 117-125
92. Vasan R.S., Sullivan L.M., Roubenoff R., et al. Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation 107 (2003) 1486-1491
93. Verma S., Kuliszewski M.A., Li S.H., et al. C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function. Circulation 109 (2004) 2058-2067
94. Volpato S., Guralnik J.M., Ferrucci L., et al. Cardiovascular disease, interleukin-6, and risk of mortality in older women: the women's health and aging study. Circulation 103 (2001) 947-953
95. Wikby A., Maxson P., Olsson J., et al. Changes in CD8 and CD4 lymphocyte subsets, T cell proliferative responses and non-survival in the very old: the Swedish longitudinal OCTO immune study. Mech. Ageing Dev. 102 (1998) 187-198
96. Wikby A., Johansson B., Olsson J., et al. Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study. Exp. Gerontol. 37 (2002) 445-453
97. Wills M.R., Okecha G., Weekes M.P., et al. Identification of naive or antigen-experienced human CD8+ T cells by expression of costimulation and chemokine receptors: analysis of the human cytomegalovirus-specific CD8+ T cell response. J. Immunol. 168 (2002) 5155-5161
98. Yeh S.S., Hafner A., Chang C.K., et al. Risk factors relating blood markers of inflammation and nutritional status to survival in cachectic geriatric patients in a randomized clinical trial. J. Am. Geriatr. Soc. 52 (2004) 1708-1712
99. Zanni F., Vescovini R., Biasini C., et al. Marked increase with age of type 1 cytokines within memory and effector/cytotoxic CD8+ T cells in humans: a contribution to understand the relationship between inflammation and immunosenescence. Exp. Gerontol. 38 (2003) 981-987
100. Zhang X., Fujii H., Kishimoto H., et al. Aging leads to disturbed homeostasis of memory phenotype CD8+ cells. J. Exp. Med. 195 (2002) 283-293